Coming Drug Price Transparency Requirements and Compliance Implications
-
Jeffrey Lewis, Director of Compliance, Rx Savings Solution.
Tricia Beckmann, Director, Faegre Drinker Biddle & Reath.
2023-02-02
-
Survey the current regulatory landscape and the underlying needs for drug price transparency
-
Understand how to comply with new CMS regulations for commercial and Medicare plans with RTBTs
-
How RTBTs create savings and curb high costs incurred by plans and beneficiaries
THIS DOCUMENT IS ONLY AVAILABLE TO MEMBERS OR ATTENDEES. PLEASE LOG IN OR PURCHASE ACCESS.
THIS RECORDING IS ONLY AVAILABLE TO ATTENDEES AND PURCHASERS. PLEASE LOG IN OR PURCHASE ACCESS.